KONINKLIJKE PHILIPS NV (PHIA.AS)
NL0000009538 - Common Stock
Overall PHIA gets a fundamental rating of 3 out of 10. We evaluated PHIA against 55 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHIA have multiple concerns. PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHIA was profitable.
In the past year PHIA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
Of the past 5 years PHIA 4 years had a positive operating cash flow.
1.2 Ratios
PHIA's Return On Assets of -1.43% is on the low side compared to the rest of the industry. PHIA is outperformed by 61.54% of its industry peers.
Looking at the Return On Equity, with a value of -3.54%, PHIA is doing worse than 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROIC | N/A |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 41.56%, PHIA is doing worse than 71.15% of the companies in the same industry.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
PHIA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% |
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
PHIA has less shares outstanding than it did 1 year ago.
PHIA has more shares outstanding than it did 5 years ago.
PHIA has a worse debt/assets ratio than last year.
2.2 Solvency
PHIA has an Altman-Z score of 1.60. This is a bad value and indicates that PHIA is not financially healthy and even has some risk of bankruptcy.
PHIA has a Altman-Z score (1.60) which is comparable to the rest of the industry.
The Debt to FCF ratio of PHIA is 7.27, which is on the high side as it means it would take PHIA, 7.27 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 7.27, PHIA perfoms like the industry average, outperforming 59.62% of the companies in the same industry.
A Debt/Equity ratio of 0.60 indicates that PHIA is somewhat dependend on debt financing.
PHIA has a worse Debt to Equity ratio (0.60) than 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Altman-Z | 1.6 |
ROIC/WACCN/A
WACC6.09%
2.3 Liquidity
A Current Ratio of 1.16 indicates that PHIA should not have too much problems paying its short term obligations.
PHIA's Current ratio of 1.16 is on the low side compared to the rest of the industry. PHIA is outperformed by 73.08% of its industry peers.
PHIA has a Quick Ratio of 1.16. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
PHIA has a Quick ratio of 0.74. This is in the lower half of the industry: PHIA underperforms 67.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.65% over the past year.
PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.67% yearly.
PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -2.65%.
PHIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.05% yearly.
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
3.2 Future
Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.64% on average per year.
The Revenue is expected to grow by 4.04% on average over the next years.
EPS Next Y20.42%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
EPS Next 5Y16.64%
Revenue Next Year-0.83%
Revenue Next 2Y1.72%
Revenue Next 3Y2.71%
Revenue Next 5Y4.04%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.98 indicates a rather expensive valuation of PHIA.
80.77% of the companies in the same industry are more expensive than PHIA, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of PHIA to the average of the S&P500 Index (27.54), we can say PHIA is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 14.64, the valuation of PHIA can be described as correct.
Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than 78.85% of the companies in the same industry.
PHIA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.99.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.98 | ||
| Fwd PE | 14.64 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as PHIA.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 84.62% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.25 | ||
| EV/EBITDA | 29.64 |
4.3 Compensation for Growth
PHIA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHIA's earnings are expected to grow with 15.06% in the coming years.
PEG (NY)0.93
PEG (5Y)N/A
EPS Next 2Y16.17%
EPS Next 3Y15.06%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.15%, PHIA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.41, PHIA pays a better dividend. On top of this PHIA pays more dividend than 96.15% of the companies listed in the same industry.
PHIA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
5.2 History
The dividend of PHIA decreases each year by -65.46%.
Dividend Growth(5Y)-65.46%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of PHIA are negative and hence is the payout ratio. PHIA will probably not be able to sustain this dividend level.
DP-0.48%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
KONINKLIJKE PHILIPS NV
AMS:PHIA (12/24/2024, 7:00:00 PM)
24.49
+0.16 (+0.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.12%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.02B
Analysts71.85
Price Target28.9 (18.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
Dividend Growth(5Y)-65.46%
DP-0.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.06%
Min EPS beat(2)-13.15%
Max EPS beat(2)-6.96%
EPS beat(4)1
Avg EPS beat(4)-8.37%
Min EPS beat(4)-25.88%
Max EPS beat(4)12.53%
EPS beat(8)3
Avg EPS beat(8)19.85%
EPS beat(12)3
Avg EPS beat(12)2.62%
EPS beat(16)7
Avg EPS beat(16)5.54%
Revenue beat(2)0
Avg Revenue beat(2)-2.71%
Min Revenue beat(2)-2.95%
Max Revenue beat(2)-2.46%
Revenue beat(4)0
Avg Revenue beat(4)-3.39%
Min Revenue beat(4)-7.41%
Max Revenue beat(4)-0.75%
Revenue beat(8)2
Avg Revenue beat(8)-0.89%
Revenue beat(12)2
Avg Revenue beat(12)-1.44%
Revenue beat(16)2
Avg Revenue beat(16)-3.44%
PT rev (1m)-3.32%
PT rev (3m)2.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.98 | ||
| Fwd PE | 14.64 | ||
| P/S | 1.27 | ||
| P/FCF | 20.25 | ||
| P/OCF | 12.79 | ||
| P/B | 1.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 29.64 |
EPS(TTM)1.29
EY5.27%
EPS(NY)1.67
Fwd EY6.83%
FCF(TTM)1.21
FCFY4.94%
OCF(TTM)1.92
OCFY7.82%
SpS19.29
BVpS12.64
TBVpS-1.53
PEG (NY)0.93
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% | ||
| FCFM | 6.27% |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
F-Score5
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Debt/EBITDA | 7.18 | ||
| Cap/Depr | 51.64% | ||
| Cap/Sales | 3.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 181.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 1.6 |
F-Score5
WACC6.09%
ROIC/WACCN/A
Cap/Depr(3y)53.02%
Cap/Depr(5y)58.22%
Cap/Sales(3y)4.17%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
EPS Next Y20.42%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
EPS Next 5Y16.64%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
Revenue Next Year-0.83%
Revenue Next 2Y1.72%
Revenue Next 3Y2.71%
Revenue Next 5Y4.04%
EBIT growth 1Y20.11%
EBIT growth 3Y-39.56%
EBIT growth 5Y-26.36%
EBIT Next Year69.31%
EBIT Next 3Y25.78%
EBIT Next 5YN/A
FCF growth 1Y-60.7%
FCF growth 3Y-2.55%
FCF growth 5Y0.39%
OCF growth 1Y-51.1%
OCF growth 3Y-5.06%
OCF growth 5Y-1.42%